VIEMED HEALTHCARE, INC. (VMD) Form 8-K — Nov 4, 2026
Viemed Healthcare reported record third-quarter 2026 revenue of $80.7 million, up 12.2% year over year, with net income attributable to Viemed of $4.6 million ($0.11 diluted EPS), up 32% YoY and 67.8% sequentially. Adjusted EBITDA rose 24.4% sequentially to $17.1 million, reaching 21.1% of revenue as operating leverage improved markedly. Growth was broad-based: PAP therapy patients jumped 37.5% YoY to 43,861, sleep resupply patients grew 22.1% to 40,918, and ventilator rental revenue rose 7.4% to $37.5 million.
Key figures
- Eps
- 0.11
- Revenue
- 80700000
- Guidance
- FY2026 net revenue $316M-$320M (raised low end from $314M); Adjusted EBITDA $64M-$66M (narrowed from $64M-$68M); net capex 8.0%-9.0% of revenue (lowered from 8.5%-10.0%)
- Net Income
- 4638000
- Total Debt
- 4510000
- Total Assets
- 207634000
- Cash Position
- 9676000
- Vent patients
- 12552
- Free cash flow q3
- 4025000
- Adjusted ebitda q3
- 17057000
- Ttm free cash flow
- 26056000
- Pap therapy patients
- 43861
- Shares repurchased q3
- 115000
- Sleep resupply patients
- 40918
- Ttm operating cash flow
- 53901000
- Ventilator rental revenue
- 37500000
- Credit facility availability
- 46000000
AI analysis
Red flags3 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.